Cofact

Revision as of 00:01, 9 August 2012 by WikiBot (talk | contribs) (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

WikiDoc Resources for Cofact

Articles

Most recent articles on Cofact

Most cited articles on Cofact

Review articles on Cofact

Articles on Cofact in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Cofact

Images of Cofact

Photos of Cofact

Podcasts & MP3s on Cofact

Videos on Cofact

Evidence Based Medicine

Cochrane Collaboration on Cofact

Bandolier on Cofact

TRIP on Cofact

Clinical Trials

Ongoing Trials on Cofact at Clinical Trials.gov

Trial results on Cofact

Clinical Trials on Cofact at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Cofact

NICE Guidance on Cofact

NHS PRODIGY Guidance

FDA on Cofact

CDC on Cofact

Books

Books on Cofact

News

Cofact in the news

Be alerted to news on Cofact

News trends on Cofact

Commentary

Blogs on Cofact

Definitions

Definitions of Cofact

Patient Resources / Community

Patient resources on Cofact

Discussion groups on Cofact

Patient Handouts on Cofact

Directions to Hospitals Treating Cofact

Risk calculators and risk factors for Cofact

Healthcare Provider Resources

Symptoms of Cofact

Causes & Risk Factors for Cofact

Diagnostic studies for Cofact

Treatment of Cofact

Continuing Medical Education (CME)

CME Programs on Cofact

International

Cofact en Espanol

Cofact en Francais

Business

Cofact in the Marketplace

Patents on Cofact

Experimental / Informatics

List of terms related to Cofact

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Cofact is a combination of blood clotting factors II, VII, IX and X. It consists of a protein fraction prepared from fresh-frozen human blood plasma. It is used in patients receiving oral anticoagulation therapy for the treatment and prevention of thrombosis when bleeding occurs (e.g. in the brain) requiring rapid action to accelerate coagulation. It is also used when such a patient must undergo an emergency operation treatment. Other indications include a deficiency of one of the included clotting factors, either congenital or due to liver disease. It is available as a powder and solvent for solution for injection.

External links


Template:WS